WDFY4 and neoplasm: Nonetheless, it will be important to identify the interacting partners of WDFY4 to uncover the pathway activated in cDC1 during the processing of tumor-derived antigens, as this information may yield insights into how to obtain cross-presenting cells that may be useful in a cell-based immunotherapy regimen.